D

Dyadic International

DYAI

1.35000

USD

-0.06

(-4.26%)

Market Closed

Volume

42

EPS

0

Div Yield

0

P/E

-4

Market Cap

30,656,745

Overview Signals Ideas News

Related Instruments

A

-0.05000

(-0.83%)

5.99000 USD

A

-0.22000

(-5.58%)

3.72000 USD

A

-0.27000

(-4.24%)

6.10000 USD

C

-0.17000

(-4.19%)

3.89000 USD

P

0.480

(2.91%)

16.990 USD

P

-0.03000

(-1.79%)

1.65000 USD

S

0.08000

(6.90%)

1.24000 USD

X

0.630

(1.46%)

43.790 USD

AI Stocks Are Booming But Could Be Overvalued Now

3 months ago

Google Joins Other Tech Giants Flocking to Southeast Asia

4 months ago

Utilities Surge Amid AI Boom

5 months ago

Novo Nordisk Surges in Profit and Sales

6 months ago

South Korea Commits $7 Billion to AI Chipmaking

6 months ago

Title: Dyadic International

Sector: Healthcare

Industry: Biotechnology

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology tothird parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.